Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

32 biomedical and clinical sciences (for-2020), 3202 clinical sciences (for-2020), 3211 oncology and carcinogenesis (for-2020), women's health (rcdc), clinical research (rcdc), biomedical imaging (rcdc), cancer (rcdc), clinical trials and supportive activities (rcdc)